LY-377604

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLY-377604
Drug Alias NameLY-377604
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonistsBeta-2 adrenergic receptor antagonistsBeta-3 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptorBeta-3 adrenergic receptorBeta-1 adrenergic receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A